Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia

NCT00944970 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

578

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: binodenoson
DRUG: adenosine

Sponsor

Pfizer